4.7 Article

The KEAP1-NRF2 pathway: Targets for therapy and role in cancer

Journal

REDOX BIOLOGY
Volume 63, Issue -, Pages -

Publisher

ELSEVIER
DOI: 10.1016/j.redox.2023.102726

Keywords

NRF2; KEAP1; Cancer; Gene regulation

Ask authors/readers for more resources

The KEAP1-NRF2 pathway is a crucial regulator of cellular defense against oxidative and electrophilic stimuli, playing a significant role in various disease pathologies. Research focused on understanding NRF2 signaling and its downstream effects has led to the identification of novel therapeutic targets. This graphical review provides an updated overview of the KEAP1-NRF2 signaling, highlighting recent advancements in the field, including the mechanism of NRF2 activation and its potential application in cancer diagnostics and treatment.
The KEAP1-NRF2 pathway is the key regulator of cellular defense against both extrinsic and intrinsic oxidative and electrophilic stimuli. Since its discovery in the 1990s, its seminal role in various disease pathologies has become well appreciated, motivating research to elucidate the intricacies of NRF2 signaling and its downstream effects to identify novel targets for therapy. In this graphical review, we present an updated overview of the KEAP1-NRF2 signaling, focusing on the progress made within the past ten years. Specifically, we highlight the advances made in understanding the mechanism of activation of NRF2, resulting in novel discoveries in its therapeutic targeting. Furthermore, we will summarize new findings in the rapidly expanding field of NRF2 in cancer, with important implications for its diagnostics and treatment.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available